Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nanoviricides Inc (NY: NNVC ) 2.240 +0.040 (+1.82%) Official Closing Price Updated: 8:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 162,133 Open 2.170 Bid (Size) 2.150 (36) Ask (Size) 2.330 (5) Prev. Close 2.200 Today's Range 2.160 - 2.350 52wk Range 1.000 - 3.590 Shares Outstanding 11,814,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News COVID is Here to Stay and NV-387 is a Much Needed Drug Against It, Reminds NanoViricides July 24, 2024 Via ACCESSWIRE A Single Drug Against Multiple Respiratory Virus Infections - COVID, RSV, Influenza, Bird Flu - Planning Next Phase of Clinical Trials, Says NanoViricides July 11, 2024 Via ACCESSWIRE Performance YTD +117.48% +117.48% 1 Month +23.08% +23.08% 3 Month +103.64% +103.64% 6 Month +109.35% +109.35% 1 Year +47.37% +47.37% More News Read More NanoViricides is Well Positioned with Its Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virus Killing, Technology Platform Intending To Revolutionize Treatment of Viral Infections July 01, 2024 Via ACCESSWIRE A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides June 24, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Thursday's Intraday Session June 20, 2024 Via Benzinga Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral Effect June 11, 2024 Via ACCESSWIRE The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect June 04, 2024 Via ACCESSWIRE A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More May 29, 2024 Via ACCESSWIRE Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model June 20, 2024 Via ACCESSWIRE Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 12, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 10, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday June 06, 2024 Via InvestorPlace Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure May 20, 2024 Via ACCESSWIRE NanoViricides Has Filed its Quarterly Report May 15, 2024 Via ACCESSWIRE A Novel Broad-Spectrum Antiviral with Activity Against RSV May 14, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Wednesday's After-Market Session June 05, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session June 03, 2024 Via Benzinga NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results May 29, 2024 Via AB Newswire NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc. May 23, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Thursday's Intraday Session May 16, 2024 Via Benzinga NNVC Stock Earnings: Nanoviricides Beats EPS for Q3 2024 May 15, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.